Showing results (1561-1570 of 1,825) with videos related to

Sort By:
Pageof 183
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2015
CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV InfectionMichael L Freeman, Joseph C Mudd, Carey L Shive, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 25, 2022
First Application of the LAMPOON Procedure to a Surgical Mitral BioprosthesisNorihiko Kamioka, Adam B Greenbaum, Robert J Lederman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2018
Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314Priscilla Y Hsue, Heather J Ribaudo, Steven G Deeks, et al.
The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.
JACC. Clinical Electrophysiology|June 24, 2023
EDEN (Electrocardiographic Radial Depth Navigation): A Novel Approach to Navigate Inside Heart MuscleChristopher G Bruce, D Korel Yildirim, Aravindan Kolandaivelu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 8, 2019
X-ray fused with MRI guidance of pre-selected transcatheter congenital heart disease interventionsElena K Grant, Joshua P Kanter, Laura J Olivieri, et al.
The New England Journal of Medicine|October 10, 1996
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study TeamS M Hammer, D A Katzenstein, M D Hughes, et al.
The Journal of Infectious Diseases|November 17, 2006
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138Michael M Lederman, Laura Smeaton, Kim Y Smith, et al.
Pathogens & Immunity|March 8, 2024
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
Blood|February 10, 2006
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cellsMichael R Betts, Martha C Nason, Sadie M West, et al.
Pageof 183